Prosecution Insights
Last updated: August 18, 2026

Examiner: BERTAGNA, ANGELA MARIE

Tech Center 1600 • Art Units: 1637 1681

This examiner grants 45% of resolved cases

Performance Statistics

44.6%
Allow Rate
-15.4% vs TC avg
739
Total Applications
+46.3%
Interview Lift
1417
Avg Prosecution Days
Based on 709 resolved cases, 2023–2026

Rejection Statute Breakdown

5.8%
§101 Eligibility
12.1%
§102 Novelty
37.0%
§103 Obviousness
34.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18220183 METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING Final Rejection Natera, Inc.
17920379 UNIVERSAL PRIMERS FOR DETECTION OF BACTERIA, FUNGI AND EUKARYOTIC MICROORGANISMS Final Rejection The Regents of the University of California
18459672 METHODS FOR DETERMINING A NUCLEOTIDE SEQUENCE CONTIGUOUS TO A KNOWN TARGET NUCLEOTIDE SEQUENCE Non-Final OA THE GENERAL HOSPITAL CORPORATION
18146320 FLOW CELLS AND METHODS Final Rejection ILLUMINA CAMBRIDGE LIMITED
17845084 SERIAL FORMATION OF TERNARY COMPLEX SPECIES Final Rejection ILLUMINA CAMBRIDGE LIMITED
17886126 METHODS AND KITS FOR DEPLETING UNDESIRED NUCLEIC ACIDS Final Rejection Revvity Health Sciences, Inc.
18176418 COMPOSITIONS FOR SURFACE AMPLIFICATION AND USES THEREOF Non-Final OA Ultima Genomics, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month